Hughes Financial Services’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$65 Buy
+4
New +$60 ﹤0.01% 1707
2026
Q2
– Sell
-6
Closed -$114 – 1931
2026
Q1
$114 Sell
6
-1
-14% -$16 ﹤0.01% 1257
2025
Q4
$122 Buy
+7
New +$132 ﹤0.01% 1041

Other funds holding SMMT

Hughes Financial Services's SMMT Position: Q3 2026 in Review

Hughes Financial Services opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 4 shares worth $65. The stake represents ﹤0.01% of the portfolio and ranks #1707 among its holdings. This is a return to the name: Hughes Financial Services previously reported a position in SMMT as recently as Q1 2026.

Hughes Financial Services first reported a position in SMMT in Q4 2025 and has held it in 3 quarters since. The position peaked at $122 in Q4 2025. 298 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.

  • Hughes Financial Services held 4 shares of Summit Therapeutics worth $65 as of Q3 2026.
  • Summit Therapeutics was a new Hughes Financial Services position in Q3 2026.
  • Summit Therapeutics made up ﹤0.01% of Hughes Financial Services's portfolio in Q3 2026, its #1707 holding.
  • Hughes Financial Services first reported a position in Summit Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Hughes Financial Services's Summit Therapeutics position peaked at $122 in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.

Based on Hughes Financial Services's 13F filing for Q3 2026, filed 30 Oct 2026.